These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32242326)

  • 1. Allan-Herndon-Dudley-Syndrome: Considerations about the Brain Phenotype with Implications for Treatment Strategies.
    Krude H; Biebermann H; Schuelke M; Müller TD; Tschöp M
    Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):414-422. PubMed ID: 32242326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.
    Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K
    Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad.
    Morte B; Gil-Ibañez P; Heuer H; Bernal J
    Thyroid; 2021 Jun; 31(6):985-993. PubMed ID: 33307956
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency.
    Kersseboom S; Horn S; Visser WE; Chen J; Friesema EC; Vaurs-Barrière C; Peeters RP; Heuer H; Visser TJ
    Mol Endocrinol; 2014 Dec; 28(12):1961-70. PubMed ID: 25389909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal Treatment of Thyroid Hormone Cell Membrane Transport Defect Caused by
    Refetoff S; Pappa T; Williams MK; Matheus MG; Liao XH; Hansen K; Nicol L; Pierce M; Blasco PA; Wiebers Jensen M; Bernal J; Weiss RE; Dumitrescu AM; LaFranchi S
    Thyroid; 2021 May; 31(5):713-720. PubMed ID: 32746752
    [No Abstract]   [Full Text] [Related]  

  • 6. Myelination Delay and Allan-Herndon-Dudley Syndrome Caused by a Novel Mutation in the SLC16A2 Gene.
    La Piana R; Vanasse M; Brais B; Bernard G
    J Child Neurol; 2015 Sep; 30(10):1371-4. PubMed ID: 25380603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
    Armour CM; Kersseboom S; Yoon G; Visser TJ
    PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations.
    Remerand G; Boespflug-Tanguy O; Tonduti D; Touraine R; Rodriguez D; Curie A; Perreton N; Des Portes V; Sarret C;
    Dev Med Child Neurol; 2019 Dec; 61(12):1439-1447. PubMed ID: 31410843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment.
    Zung A; Visser TJ; Uitterlinden AG; Rivadeneira F; Friesema EC
    Eur J Endocrinol; 2011 Nov; 165(5):823-30. PubMed ID: 21896621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 7-month-old male with Allan-Herndon-Dudley syndrome and the power of T3.
    Langley KG; Trau S; Bean LJ; Narravula A; Schrier Vergano SA
    Am J Med Genet A; 2015 May; 167A(5):1117-20. PubMed ID: 25755011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial.
    Groeneweg S; Peeters RP; Moran C; Stoupa A; Auriol F; Tonduti D; Dica A; Paone L; Rozenkova K; Malikova J; van der Walt A; de Coo IFM; McGowan A; Lyons G; Aarsen FK; Barca D; van Beynum IM; van der Knoop MM; Jansen J; Manshande M; Lunsing RJ; Nowak S; den Uil CA; Zillikens MC; Visser FE; Vrijmoeth P; de Wit MCY; Wolf NI; Zandstra A; Ambegaonkar G; Singh Y; de Rijke YB; Medici M; Bertini ES; Depoorter S; Lebl J; Cappa M; De Meirleir L; Krude H; Craiu D; Zibordi F; Oliver Petit I; Polak M; Chatterjee K; Visser TJ; Visser WE
    Lancet Diabetes Endocrinol; 2019 Sep; 7(9):695-706. PubMed ID: 31377265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations.
    Anık A; Kersseboom S; Demir K; Catlı G; Yiş U; Böber E; van Mullem A; van Herebeek RE; Hız S; Abacı A; Visser TJ
    Horm Res Paediatr; 2014; 82(4):261-71. PubMed ID: 25247785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel A178P mutation in SLC16A2 in a patient with Allan-Herndon-Dudley syndrome.
    Yamamoto T; Lu Y; Nakamura R; Shimojima K; Kira R
    Congenit Anom (Kyoto); 2018 Jul; 58(4):143-144. PubMed ID: 28862359
    [No Abstract]   [Full Text] [Related]  

  • 14. MCT8 deficiency in Purkinje cells disrupts embryonic chicken cerebellar development.
    Delbaere J; Vancamp P; Van Herck SL; Bourgeois NM; Green MJ; Wingate RJ; Darras VM
    J Endocrinol; 2017 Feb; 232(2):259-272. PubMed ID: 27879339
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Groeneweg S; Kersseboom S; van den Berge A; Dolcetta-Capuzzo A; van Geest FS; van Heerebeek REA; Arjona FJ; Meima ME; Peeters RP; Visser WE; Visser TJ
    Thyroid; 2019 Oct; 29(10):1499-1510. PubMed ID: 31436139
    [No Abstract]   [Full Text] [Related]  

  • 16. Spatiotemporal Changes of Cerebral Monocarboxylate Transporter 8 Expression.
    Wilpert NM; Krueger M; Opitz R; Sebinger D; Paisdzior S; Mages B; Schulz A; Spranger J; Wirth EK; Stachelscheid H; Mergenthaler P; Vajkoczy P; Krude H; Kühnen P; Bechmann I; Biebermann H
    Thyroid; 2020 Sep; 30(9):1366-1383. PubMed ID: 32143555
    [No Abstract]   [Full Text] [Related]  

  • 17. Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.
    Lee JY; Kim MJ; Deliyanti D; Azari MF; Rossello F; Costin A; Ramm G; Stanley EG; Elefanty AG; Wilkinson-Berka JL; Petratos S
    EBioMedicine; 2017 Nov; 25():122-135. PubMed ID: 29111262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Efficacy of T3 Analogue Triac in Children and Adults With MCT8 Deficiency: A Real-Life Retrospective Cohort Study.
    van Geest FS; Groeneweg S; van den Akker ELT; Bacos I; Barca D; van den Berg SAA; Bertini E; Brunner D; Brunetti-Pierri N; Cappa M; Cappuccio G; Chatterjee K; Chesover AD; Christian P; Coutant R; Craiu D; Crock P; Dewey C; Dica A; Dimitri P; Dubey R; Enderli A; Fairchild J; Gallichan J; Garibaldi LR; George B; Hackenberg A; Heinrich B; Huynh T; Kłosowska A; Lawson-Yuen A; Linder-Lucht M; Lyons G; Monti Lora F; Moran C; Müller KE; Paone L; Paul PG; Polak M; Porta F; Reinauer C; de Rijke YB; Seckold R; Menevşe TS; Simm P; Simon A; Spada M; Stoupa A; Szeifert L; Tonduti D; van Toor H; Turan S; Vanderniet J; de Waart M; van der Wal R; van der Walt A; van Wermeskerken AM; Wierzba J; Zibordi F; Zung A; Peeters RP; Visser WE
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1136-e1147. PubMed ID: 34679181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course and images of four familial cases of Allan-Herndon-Dudley syndrome with a novel monocarboxylate transporter 8 gene mutation.
    Kobayashi S; Onuma A; Inui T; Wakusawa K; Tanaka S; Shimojima K; Yamamoto T; Haginoya K
    Pediatr Neurol; 2014 Sep; 51(3):414-6. PubMed ID: 25160547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired T3 uptake and action in MCT8-deficient cerebral organoids underlie Allan-Herndon-Dudley syndrome.
    Salas-Lucia F; Escamilla S; Bianco AC; Dumitrescu A; Refetoff S
    JCI Insight; 2024 Feb; 9(7):. PubMed ID: 38376950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.